[1] Mani H,Thiel DHV.Mesenchymal tumors of the liver.Clin Liver Dis,2001,5(1):219-257.
[2] Molina E,Hernandez A.Clinical manifestations of primary hepatic angiosarcoma.Dig Dis Sci,2003,48(4):677-682.
[3] Noor M,Leyva A,Patacsil SJ,et al.Hepatic angiosarcoma:a case presentation.Cureus,2020,12(2):e6848.
[4] Averbukh LD,Mavilia MG,Einstein MM.Hepatic angiosarcoma:a challenging diagnosis.Cureus,2018,10(9):e3283.
[5] Locker GY,Doroshow JH,Zwelling LA,et al.The clinical features of hepatic angiosarcoma:a report of four cases and a review of the English literature.Medicine (Baltimore),1979,58(1):48-64.
[6] Yi LL,Zhang JX,Zhou SG,et al.CT and MRI studies of hepatic angiosarcoma.Clin Radiol,2019,74(5):406.e1-406.e8.
[7] Zheng K,Liu Y,Cui RX,et al.Primary spleen angiosarcoma with concomitant hepatic hemangiomas on 18F-FDG PET/CT.Clin Nucl Med,2018,43(3):222-223.
[8] Li DB,Si XY,Wan T,et al.A pooled analysis of treatment and prognosis of hepatic angiosarcoma in adults.Hepatobiliary Pancreat Dis Int,2018,17(3):198-203.
[9] Zheng YW,Zhang XW,Zhang JL,et al.Primary hepatic angiosarcoma and potential treatment options.J Gastroenterology Hepatol,2014,29(5):906-911.
[10] Almogy G,Lieberman S,Gips M,et al.Clinical outcomes of surgical resections for primary liver sarcoma in adults:results from a single centre.Eur J Surg Oncol,2004,30(2):421-427.
[11] Kim HR,Rha SY,Cheon SH,et al.Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma.Ann Oncol,2009.20(4):780-787.
[12] 刘洁.原发性肝血管肉瘤临床特点分析.安徽医科大学,2019.
[13] Lee SW,Song CY,Gi YH,et al.Hepatic angiosarcoma manifested as recurrent hemoperitoneum.World J Gastroenterol,2008,14(18):2935-2938.
[14] 张波,曹瑞,刘泽峰,等.环磷酰胺、紫杉醇致小鼠血小板、白细胞减少模型的复制研究.现代中医药,2011,31(03):56-57.
[15] Singh G,Mills C,Asadi K,et al.Hepatic angiosarcoma as a cause of acute liver failure.BMJ Case Rep,2018,2018:bcr2018225896. |
